source
- China could ‘corner’ biopharmaceutical sector with new plan, US panel warnsA commission called on U.S. lawmakers to act quickly to prevent an “overdependence” on China that could leave American patients “vulnerable to supply chain weaponization.”BioPharma Dive · 34m ago↗ source
- Chinese AI lab MegaRobo raises nearly $200M; Isomorphic partners with MerckPlus news about Adcendo, Biohaven, Sellas, Yuanshi, VitriVax and Ansa Biotechnologies. MegaRobo raises nearly $200 million: The Chinese AI and lab-automation company announced the raise in a post o…Endpoints · 34m ago↗ source
- Sanofi considering a deal to acquire Insmed, according to reportSanofi is looking at a deal to buy the US drugmaker Insmed, Bloomberg News reported Thursday, in what would be one of the biggest biopharma takeovers of the last several years. The Bloomberg report…